Current and potential therapeutic uses of growth hormone and insulin- like growth factor I

Endocrinology and Metabolism Clinics of North America

Volumn 25, Issue 3, 1996, Pages 759-773

  Hintz, R L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CARBOHYDRATE METABOLISM; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DRUG INDICATION; FERTILITY; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HUMAN; LIPID METABOLISM; PRIORITY JOURNAL; REVIEW; SHORT STATURE; TREATMENT OUTCOME; TURNER SYNDROME;

EID: 0029808249     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70352-2     Document Type: Article

References (75)

1. M.S. Agus L.E. Katz M. Satin-Smith Non-islet-cell tumor associated with hypoglycemia in a child: Successful long-term therapy with growth hormone J Pediatr 127 1995 403 407
2. D.B. Allen C.G. Brook N.A. Bridges Therapeutic controversies: Growth hormone (GH) treatment of non-GH deficient subjects J Clin Endocrinol Metab 79 1994 1239 1248
3. G. Anneren J. Gustafsson V.R. Sara Normalized growth velocity in children with Down's syndrome during growth hormone therapy J Int Dis Res 37 1993 381 387
4. K.M. Attie L.M. Carlsson A.C. Rundle Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. The National Cooperative Growth Study J Pediatr 127 1995 244 250
5. P.F. Backeljauw C. Alves M. Eidson Effect of intravenous insulin-like growth factor I in two patients with leprechaunism Pediatr Res 36 1994 749 754
6. M.D. Bain S.S. Nussey M. Jones Use of human somatotrophin in the treatment of a patient with methylmalonic aciduria Eur J Pediatr 154 1995 850 852
7. R. Balducci V. Toscano A. Mangiantini Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone J Clin Endocrinol Metab 80 1995 3596 3600
8. S.W. Behrman K.A. Kudsk R.O. Brown The effect of growth hormone on nutritional markers in enterally fed immobilized trauma patients J Parenter Enter Nutr 19 1995 41 46
9. C. Bergh T. Hillensjo M. Wikland Adjuvant growth hormone treatment during in vitro fertilization: A randomized, placebo-controlled study Fertil Steril 62 1994 113 120
10. S.A. Beshyah P. Kyd E. Thomas The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults Clin Endocrinol 42 1995 249 254
11. P.G. Blake Growth hormone and malnutrition in dialysis patients Perit Dial Int 15 1995 210 216
12. S.L. Blethen Complications of growth hormone therapy in children Curr Opin Pediatr 7 1995 466 471
13. W.F. Blum A.M. Cotterill M.C. Postel-Vinay Improvement of diagnostic criteria in growth hormone insensitivity syndrome: Solutions and pitfalls. Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes Acta Paediatr 399 suppl 1994 117 124
14. N.A. Bridges C.G. Brook Progress report: Growth hormone in skeletal dysplasia Horm Res 42 1994 231 234
15. B.M. Chavers L. Doherty T.E. Nevins Effects of growth hormone on kidney function in pediatric transplant recipients Pediatr Nephrol 9 1995 176 181
16. T.D. Cheetham K.L. Clayton A.M. Taylor The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin-dependent diabetes mellitus Clin Endocrinol 40 1994 515 522
17. W.G. Cioffi D.C. Gore L.W. Rue Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury Ann Surg 220 1994 310 316
18. D.R. Clemmons L.E. Underwood Clinical review 59: Uses of human insulin-like growth factor-I in clinical conditions J Clin Endocrinol Metab 79 1994 4 6
19. E. Corpas S.M. Harman M.R. Blackman Human growth gormone and human aging Endocr Rev 14 1993 20 39
20. D.B. Dunger Insulin and insulin-like growth factors in diabetes mellitus Arch Dis Child 72 1995 469 471
21. R.N. Fine Recombinant human growth hormone (rhGH) in dialysis patients: Update 1995 Adv Perit Dial 11 1995 261 265
22. R.N. Fine E.C. Kohaut D. Brown Growth after recombinant human growth hormone treatment in children with chronic renal failure: Report of a multicenter randomized double-blind placebo-controlled study J Pediatr 124 1994 374 382
23. J. Guevarra-Aguirre O. Vasconez V. Martinez A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency J Clin Endocrinol Metab 80 1995 1393 1398
24. H.J. Guyda Use of GH in children with short stature and normal growth hormone secretion Trends in Endocrinology and Metabolism 5 1994 334 340
25. D.N. Herndon R.E. Barrow K.R. Kunkel Effects of recombinant human growth hormone on donor-site healing in severely burned children Ann Surg 212 1990 424 429
26. D.N. Herndon H.K. Hawkins T.T. Nguyen Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns Ann Surg 221 1995 649 656
27. R.L. Hintz K.M. Attie P.G. Compton Multifactorial studies of GH treatment of Turner syndrome: The Genentech National Cooperative Growth Study K. Albertsson-Wikland B. Lippe Turner Syndrome in a Life-Span Perspective 1995 Elsevier Amsterdam
28. R.L. Hintz K.M. Attie the Genentech Study Group Near final height in GH-treated short children without classical GH deficiency [abstract] Pediatr Res 37 1995 91A
29. R.L. Hintz A.R. Hoffman G. Butterfield Effects and side effects of growth hormone treatment in the adult Z. Laron O. Butenandt Growth Hormone Replacement Therapy in the Adult: Pros and Cons 1993 Freund Publishing House Ltd London 157 170
30. R.L. Hintz R.G. Rosenfeld D.M. Wilson Biosynthetic methionyl-human growth hormone is biologically active in adult man Lancet I 1982 1276 1279
31. R.L. Hintz The prismatic case of Creutzfeldt-Jakob disease associated with pituitary growth hormone treatment J Clin Endocrinol Metab 80 1995 2298 2301
32. R.L. Hintz Untoward events in patients treated with GH in the USA Horm Res 38 suppl 1 1992 44 49
33. L. Holloway G. Butterfield R.L. Hintz Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women J Clin Endocrinol Metab 79 1994 470 479
34. N.J. Hopwood R.L. Hintz J.M. Gertner Growth response of non-growth hormone deficient children with marked short stature during three years of growth hormone therapy J Pediatr 123 1993 215 222
35. K.F. Huang D.H. Chung D.N. Herndon Insulinlike growth factor 1 (IGF-1) reduces gut atrophy and bacterial translocation after severe burn injury Arch Surg 128 1993 47 53
36. M.A. Hussain E.R. Froesch Clinical uses of insulin-like growth factor I Adv Endocrinol Metab 6 1995 143 165
37. N. Jabri D.S. Schalch S.L. Schwartz Adverse effects of recombinant human insulin-like growth factor-II obese insulin-resistant type II diabetic patients Diabetes 43 1994 369 374
38. J.O. Jorgensen S.B. Pedersen J. Borglum Fuel metabolism, energy expenditure, and thyroid function in growth hormone-treated obese women: A double-blind placebo-controlled study Metabolism: Clinical and Experimental 43 1994 872 877
39. J.O. Jorgensen L. Thuesen J. Muller Three years of growth hormone treatment in growth hormone-deficient adults: Near normalization of body composition and physical performance Eur J Endocrinol 130 1994 224 228
40. B. Klinger Z. Laron Three year IGF-I treatment of children with Laron syndrome J Pediatr Endocrinol Metab 8 1995 149 158
41. J.B. Koea R.G. Douglas J.H. Shaw Growth hormone therapy initiated before starvation ameliorates the catabolic state and enhances the protein-sparing effect of total parenteral nutrition Br J Surg 80 1993 740 744
42. H. Kohno N. Ueyama S. Yanai Beneficial effect of growth hormone on atherogenic risk in children with growth hormone deficiency J Pediatr 126 1995 953 955
43. Z. Laron Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient J Clin Endocrinol Metab 80 1995 1526 1531
44. P.D. Lee K. Hwu H. Henson Body composition studies in Prader-Willi syndrome: Effects of growth hormone therapy Basic Life Sci 60 1993 201 205
45. T.H. Lin R.T. Kirkland J.L. Kirkland Adult height in girls with Turner syndrome treated with low-dose estrogens and androgens Ann Pharmacother 28 1994 570 571
46. S. Loche P. Cambiaso S. Setzu Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature J Pediatr 125 1994 196 200
47. N. Longo R. Singh L.D. Griffin Impaired growth in Rabson-Mendenhall syndrome: Lack of effect of growth hormone and insulin-like growth factor-I J Clin Endocrinol Metab 79 1994 799 805
48. U. Masharani M. Schambelan The endocrine complications of acquired immunodeficiency syndrome Adv Intern Med 38 1993 323 336
49. O. Mehls B. Tonshoff D. Haffner The use of recombinant human growth hormone in short children with chronic renal failure J Pediatr Endocrinol 7 1994 107 113
50. A.C. Moses L.A. Morrow M. O'Brien Insulin-like growth factor I (rhIGF-I) as a therapeutic agent for hyperinsulinemic insulin-resistant diabetes mellitus Diabetes Res Clin Pract 28 Suppl 1995 185 194
51. N. Nakashima F. Umeda T. Yanase Insulin resistance associated with substitution of histidine for arginine 252 in the alpha-subunit of the human insulin receptor: Trial of insulin-like growth factor I injection therapy to enhance insulin sensitivity J Clin Endocrinol Metab 80 1995 3662 3667
52. H.E. Nienhuis C. Rongen-Westerlaken J.M. Wit Results of long-term therapy with growth hormone in two dose regimens in Turner syndrome. Dutch Growth Hormone Working Group Horm Res 39 Suppl 2 1993 31 36
53. H. Olivecrona A.G. Johansson E. Lindh Hormonal regulation of serum lipoprotein(a) levels: Contrasting effects of growth hormone and insulin-like growth factor-I Arterioscler Thromb Vasc Biol 15 1995 847 849
54. J. Powrie A. Weissberger P. Sonksen Growth hormone replacement therapy for growth hormone-deficient adults Drugs 49 1995 656 663
55. D.A. Price K. Albertsson-Wikland Demography, auxology and response to recombinant human growth hormone treatment in girls with Turner's syndrome in the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study Acta Paediatr 82 Suppl 391 1993 69 74
56. M.S. Raben Treatment of a pituitary dwarf with human growth hormone J Clin Endocrinol Metab 18 1958 901 903
57. A. Radicioni E. Paris F. Dondero Recombinant-growth hormone (rec-hGH) therapy in infertile men with idiopathic oligozoospermia Acta Eur Fertil 25 1994 311 317
58. L.H. Rasmussen Evaluation of recombinant human growth hormone for wound management Dan Med Bull 42 1995 358 370
59. T. Rosen B.A. Bengtsson Premature mortality due to cardiovascular disease in hypopituitarism Lancet 336 1990 285 288
60. R.G. Rosenfeld R.L. Hintz A.J. Johanson Three year results of a randomized, prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome J Pediatr 113 1988 393 400
61. R.G. Rosenfeld J. Frane K.M. Attie Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner's syndrome J Pediatr 121 1992 49 55
62. D. Rotenstein M. Adams D.H. Reigel Adult stature and anthropomorphic measurements of patients with myelomeningocele Eur J Pediatr 154 1995 398 402
63. C.D. Rubin B. Reed K. Sakhaee Treating a patient with the Werner syndrome and osteoporosis using recombinant human insulin-like growth factor Ann Intern Med 121 1994 665 668
64. G. Saggese G.I. Baroncelli S. Bertelloni Long-term growth hormone treatment in children with renal hypophosphatemic rickets: Effects on growth, mineral metabolism, and bone density J Pediatr 127 1995 395 402
65. G. Saggese G. Cesaretti S. Barsanti Combination treatment with growth hormone and gonadotropin-releasing hormone analogs in short normal girls J Pediatr 126 1995 468 473
66. K. Takano K. Shizume I. Hibi Growth hormone treatment in Turner syndrome: Results of a multicentre study in Japan. The Committee for the Treatment of Turner Syndrome Horm Res 39 Suppl 2 1993 37 41
67. J.L. Thompson G.E. Butterfield R. Marcus The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women J Clin Endocrinol Metab 80 1995 1845 1852
68. M.C. Thoren I.L. Wivall-Helleryd W.F. Blum Effects of repeated subcutaneous administration of recombinant human insulin-like growth factor I in adults with growth hormone deficiency Eur J Endocrinol 131 1994 33 40
69. E. Vlachopapadopoulou J.J. Zachwieja J.M. Gertner Metabolic and clinical response to recombinant human insulin-like growth factor I in myotonic dystrophy: A clinical research center study J Clin Endocrinol Metab 80 1995 3715 3723
70. J.L. Walker J.J. Van Wyk L.E. Underwood Stimulation of statural growth by recombinant insulin-like growth factor-I in a child with growth hormone insensitivity syndrome (Laron type) J Pediatr 121 1992 641 646
71. Z. Zadik S. Chalew A. Zung Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency J Pediatr 125 1994 189 195
72. P.D. Zenobi Y. Glatz A. Keller Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A Eur J Endocrinol 131 1994 251 257
73. T.R. Ziegler Growth hormone administration during nutritional support: What is to be gained? New Horizons 2 1994 244 256
74. T.R. Ziegler I. Leader Adjunctive human growth hormone therapy in nutrition support: Potential to limit septic complications in intensive care unit patients Sem Respir Infect 9 1994 240 247
75. T.R. Ziegler C. Gatzen D.W. Wilmore Strategies for attenuating protein-catabolic responses in the critically ill Ann Rev Med 45 1994 459 480